Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.aohep.2020.05.001 http://scihub22266oqcxt.onion/10.1016/j.aohep.2020.05.001 32425991!7233236!32425991     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ann+Hepatol 2020 ; 19 (4): 353-358 Nephropedia Template TP {{tp|p=32425991|t=2020. The liver in times of COVID-19: What hepatologists should know |pdf=|usr=}}{{32425991}} gab.com Text The liver in times of COVID-19: What hepatologists should know JO: Ann Hepatol http://www.kidney.de/pget.php?&tw=1&pmid=32425991 #FOAvip The ongoing pandemic of coronavirus disease 2019 (COVID-19) pandemic poses a serious threat to healthcare systems globally. Information regarding how the infection affects the liver and relevance of pre-existing liver disease as a risk factor for acquiring the infection or having a severe disease are still scarce. Also, considerations in liver transplant patients, those having hepatocellular carcinoma or under immunosuppressive therapy are being matter of analysis as information is being generated. Different treatments for COVID-19 are currently under study, some of which may be associated to hepatotoxicity. In the present review we discuss current data on the COVID-19 and liver, aiming to provide hepatologists with updated information to face this pandemic. Twit Text FOAVip The liver in times of COVID-19: What hepatologists should know ????Ann Hepatol http://www.kidney.de/pget.php?&tw=1&pmid=32425991 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32425991 #FOAvip English Wikipedia <ref>{{Cite pmid|32425991}}</ref> The liver in times of COVID-19: What hepatologists should know #MMPMID32425991 Ridruejo E; Soza A Ann Hepatol 2020[Jul]; 19 (4): 353-358 PMID32425991show ga The ongoing pandemic of coronavirus disease 2019 (COVID-19) pandemic poses a serious threat to healthcare systems globally. Information regarding how the infection affects the liver and relevance of pre-existing liver disease as a risk factor for acquiring the infection or having a severe disease are still scarce. Also, considerations in liver transplant patients, those having hepatocellular carcinoma or under immunosuppressive therapy are being matter of analysis as information is being generated. Different treatments for COVID-19 are currently under study, some of which may be associated to hepatotoxicity. In the present review we discuss current data on the COVID-19 and liver, aiming to provide hepatologists with updated information to face this pandemic. |*Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/*complications/*therapy[MESH] |Humans[MESH] |Liver Diseases/pathology/*therapy/*virology[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications/*therapy[MESH] |Risk Factors[MESH]The liver in times of COVID-19: What hepatologists should know (epmc).pdf DeepDyve Pubget Overpricing